CSIMarket
 


Evolutionary Genomics Inc   (FNAM)
Other Ticker:  
 
    Sector  Healthcare    Industry Medical Laboratories
   Industry Medical Laboratories
   Sector  Healthcare
 

FNAM's Free Cash Flow Growth by Quarter and Year

Evolutionary Genomics Inc 's Free Cash Flow results by quarter and year




FNAM Free Cash Flow (in millions $) FY 2022 FY 2021 FY 2020 FY 2019
IV Quarter December - -1.29 -0.48 -0.13
III Quarter September -0.13 -0.10 -0.23 -0.20
II Quarter June -0.14 -0.19 -0.03 -0.12
I Quarter March -0.18 -1.55 -0.17 -0.15
FY   -0.45 -3.13 -0.91 -0.60



FNAM Free Cash Flow third quarter 2022 Y/Y Growth Comment
Evolutionary Genomics Inc in the third quarter 2022 recorded free cash outflow of $ -0.13 millions.

According to the results reported in the third quarter 2022, Evolutionary Genomics Inc achieved the best Free Cash Flow growth in Medical Laboratories industry. While Evolutionary Genomics Inc ' s Free Cash Flow no change of % ranks overall at the positon no. in the third quarter 2022.




FNAM Free Cash Flow ( Y/Y Growth %) 2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY   - - - -

Financial Statements
Evolutionary Genomics Inc 's third quarter 2022 Free Cash Flow $ -0.13 millions FNAM's Income Statement
Evolutionary Genomics Inc 's third quarter 2021 Free Cash Flow $ -0.10 millions Quarterly FNAM's Income Statement
New: More FNAM's historic Free Cash Flow Growth >>


FNAM Free Cash Flow (Quarter on Quarter Growth %)

2022
2021 2020 2019
IV Quarter December - - - -
III Quarter September - - - -
II Quarter June - - - -
I Quarter March - - - -
FY (Year on Year)   - - - -




Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 
Free Cash Flow third quarter 2022 Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Free Cash Flow Y/Y Growth Statistics
High Average Low
0 % 0 % 0 %
 

Free Cash Flow by Quarter for the Fiscal Years 2019, 2020, 2021, 2022

Evolutionary Genomics Inc 's Q/Q Free Cash Flow Growth


Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FNAM's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Evolutionary Genomics Inc in the III. Quarter 2022 admitted free cash outflow of $ -0.13 millions, it should be point out, that those numbers point to slight up side relative to the -0.14 millions in the second quarter.

Within Medical Laboratories industry Evolutionary Genomics Inc achieved highest sequential Free Cash Flow growth. While Evolutionary Genomics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #
Free Cash Flow Q/Q Growth Statistics
High Average Low
0 % 0 % 0 %
 


FNAM's III. Quarter Q/Q Free Cash Flow Comment
Despite the fact, that Evolutionary Genomics Inc in the III. Quarter 2022 revealed free cash outflow of $ -0.13 millions, some analyst mentioned, that current results show improvement compare to the -0.14 millions in the second quarter.

Within Medical Laboratories industry Evolutionary Genomics Inc achieved highest sequential Free Cash Flow growth. While Evolutionary Genomics Inc 's Free Cash Flow growth quarter on quarter, overall rank is .


Evolutionary Genomics Inc 's 12 Months Free Cash Flow Growth Year on Year


Free Cash Flow TTM Growth

12 Months Ending
(Sep 30 2022)
12 Months Ending
(Jun 30 2022)
12 Months Ending
(Mar 31 2022)
12 Months Ending
(Dec 31 2021)
12 Months Ending
(Jun 30 2021)
Cumulative Free Cash Flow 12 Months Ending $ -1.74 $ -1.71 $ -1.76 $ -3.13 $ -2.32
Y / Y Free Cash Flow Growth (TTM) - - - - -
Year on Year Free Cash Flow Growth Overall Ranking # # # # #
Seqeuential Free Cash Flow Change (TTM) - - - - -
Seq. Free Cash Flow Growth (TTM) Overall Ranking # # # # #




Cumulative Free Cash Flow growth Comment


Evolutionary Genomics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 

Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #
Cumulative Free Cash Flow growth Comment


Evolutionary Genomics Inc achieved highest trailing twelve month year on year Free Cash Flow growth. While overall Free Cash Flow growth ranking, remained unchanged compare to the previous quarter at no. .

Free Cash Flow TTM Q/Q Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Y/Y Growth Company Ranking
Within: No.
Medical Laboratories Industry #
Healthcare Sector #
Overall #

Free Cash Flow TTM Y/Y Growth Statistics
High Average Low
0 %
0 %
0 %
 


Free Cash Flow TTM Q/Q Growth Company Ranking
Within: No.
Industry #
Sector #
S&P 500 #




Other Free Cash Flow Growth
Medical Laboratories Industry Free Cash Flow Growth Trends and Statistics
Healthcare Sector Free Cash Flow Growth Statistics
Free Cash Flow Growth Trends for overall market
FNAM's Free Cash Flow Growth Ratio versus Medical Laboratories Industry, Healthcare Sector and total Market
Highest Ranking Free Cash Flow Growth
Lowest Ranking Free Cash Flow Growth
Free Cash Flow Growth for FNAM's Competitors
Free Cash Flow Growth for Evolutionary Genomics Inc 's Suppliers
Free Cash Flow Growth for FNAM's Customers

You may also want to know
FNAM's Annual Growth Rates FNAM's Profitability Ratios FNAM's Asset Turnover Ratio FNAM's Dividend Growth
FNAM's Roe FNAM's Valuation Ratios FNAM's Financial Strength Ratios FNAM's Dividend Payout Ratio
FNAM's Roa FNAM's Inventory Turnover Ratio FNAM's Growth Rates FNAM's Dividend Comparisons



Companies with similar Free Cash Flow no change for the quarter ending Sep 30 2022 within Healthcare SectorY/Y Change %Free Cash Flow for the quarter ending Sep 30 2022
Medpace Holdings Inc 49.95%$ 49.947 millions
Lftd Partners Inc 49.63%$ 49.634 millions
Livanova Plc48.78%$ 48.783 millions
Endo International Plc47.68%$ 47.683 millions
Merit Medical Systems Inc42.09%$ 42.092 millions
United Therapeutics Corporation39.33%$ 39.332 millions
Msa Safety Inc38.28%$ 38.283 millions
Vanda Pharmaceuticals Inc 36.61%$ 36.607 millions
Pediatrix Medical Group Inc 36.38%$ 36.379 millions
Eli Lilly And Company33.93%$ 33.930 millions
Anika Therapeutics Inc 31.38%$ 31.377 millions
Davita Inc 25.32%$ 25.325 millions
Amgen Inc 23.16%$ 23.160 millions
Avanos Medical Inc 22.41%$ 22.414 millions
Te Connectivity ltd 21.96%$ 21.964 millions
Conmed Corporation21.21%$ 21.211 millions
Dexcom Inc 18.56%$ 18.560 millions
Merck and Co Inc 16.78%$ 16.781 millions
Iradimed Corporation16.58%$ 16.580 millions
Incyte Corporation16.18%$ 16.183 millions


Economy


Advance Monthly Sales

Consumer Price Index CPI

Producer Price Index PPI

Retail Inventories

Personal Income

Gross Domestic Product GDP

Money Supply

Industrial Production

Productivity

Employment Situation

US International Trade

Factory Orders

Durable Goods

Construction Spending

Housing Starts

Vehicle Unit Sales

Stocks


Event Calendar

HCP's Profile

Stock Price

HCP's Financials

Business Description

Fundamentals

Charts & Quotes

HCP's News

Suppliers

HCP's Competitors

Customers & Markets

Economic Indicators

HCP's Growth

Company Segments

Screening


Stock Performance

Growth Rates

Profitability

Valuation

Dividend

Financial Strength

Efficiency

Largest Companies

Management Effectivness

Industries


At a Glance

Performance

Growth Rates

Profitability

Valuation

Financial Strength

Markets


At a Glance

Stocks

Cryptocurrencies

Sectors & Industries

Commodities

Currencies

News


At a Glance

Stocks

Economy

Industries

Other

Help


Sitemap

Advertise

About us

Glossary


Financial Terms

Technical Analysis

Fundamental Analysis

Energy Terms

Manufacturing Terms

Transportation Terms

Health Care

Insurance Terms

Economy Terms

Hotel & Leisure Terms

CSIMarket Company, Sector, Industry, Market Analysis, Stock Quotes, Earnings, Economy, News and Research. 
   Copyright © 2023 CSIMarket, Inc. All rights reserved. This site uses cookies to make your browsing experince better. By using this site, you agree to the Terms of Service and Privacy Policy - UPDATED (Read about our Privacy Policy)

Intraday data delayed per exchange requirements. All quotes are in local exchange time. Intraday data delayed 15 minutes for Nasdaq, and other exchanges. Fundamental and financial data for Stocks, Sector, Industry, and Economic Indicators provided by CSIMarket.com
CSIMarket.com 1500 N. University Drive, Coral Springs, FL 33071